ClinicalTrials.govpublic full text
Expanded Access Use of Nogapendekin-alfa Inbakicept in the Reversal and Maintenance of Absolute Lymphocyte Count (ALC) for the Treatment of Lymphopenia Induced by Chemotherapy, Immunotherapy, and/or Radiation Therapy
lymphopenia, lymphopenia induced by chemotherapy, lymphopenia induced by radiation therapy, lymphopenia induced by immunotherapy, absolute lymphocyte count, expanded access
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 967739
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.